![Polyvalent Side Chain Peptide–Synthetic Polymer Conjugates as HIV-1 Entry Inhibitors | Biomacromolecules Polyvalent Side Chain Peptide–Synthetic Polymer Conjugates as HIV-1 Entry Inhibitors | Biomacromolecules](https://pubs.acs.org/cms/10.1021/bm300150q/asset/images/medium/bm-2012-00150q_0001.gif)
Polyvalent Side Chain Peptide–Synthetic Polymer Conjugates as HIV-1 Entry Inhibitors | Biomacromolecules
![Polyvalent Side Chain Peptide–Synthetic Polymer Conjugates as HIV-1 Entry Inhibitors | Biomacromolecules Polyvalent Side Chain Peptide–Synthetic Polymer Conjugates as HIV-1 Entry Inhibitors | Biomacromolecules](https://pubs.acs.org/cms/10.1021/bm300150q/asset/images/medium/bm-2012-00150q_0003.gif)
Polyvalent Side Chain Peptide–Synthetic Polymer Conjugates as HIV-1 Entry Inhibitors | Biomacromolecules
![JNT | Free Full-Text | Role of Tunable Gold Nanostructures in Cancer Nanotheranostics: Implications on Synthesis, Toxicity, Clinical Applications and Their Associated Opportunities and Challenges JNT | Free Full-Text | Role of Tunable Gold Nanostructures in Cancer Nanotheranostics: Implications on Synthesis, Toxicity, Clinical Applications and Their Associated Opportunities and Challenges](https://www.mdpi.com/jnt/jnt-04-00001/article_deploy/html/images/jnt-04-00001-g001.png)
JNT | Free Full-Text | Role of Tunable Gold Nanostructures in Cancer Nanotheranostics: Implications on Synthesis, Toxicity, Clinical Applications and Their Associated Opportunities and Challenges
![Polyvalent Side Chain Peptide–Synthetic Polymer Conjugates as HIV-1 Entry Inhibitors | Biomacromolecules Polyvalent Side Chain Peptide–Synthetic Polymer Conjugates as HIV-1 Entry Inhibitors | Biomacromolecules](https://pubs.acs.org/cms/10.1021/bm300150q/asset/images/medium/bm-2012-00150q_0004.gif)